BOOM
Recent additions may not be included but will usually appear in 24 hrs or less.
| Rational | Source |
|---|---|
|
Role of <i>Lactobacillus reuteri</i> in Human Health and Diseases. ✅
Go to Publication ✅
Frontiers in microbiology (Front Microbiol ) Vol: 9 Issue Pages: 757 Pub: 2018 Epub: 2018 Apr 19 Authors Mu Q , Tavella VJ , Luo XM , |
|
|
Effect of Probiotics on Pharmacokinetics of Orally Administered Acetaminophen in Mice. ✅
Go to Publication ✅
Drug metabolism and disposition: the biological fate of chemicals (Drug Metab Dispos ) Vol: 46 Issue 2 Pages: 122-130 Pub: 2018 Feb Epub: 2017 Dec 6 Authors Kim JK , Choi MS , Jeong JJ , Lim SM , Kim IS , Yoo HH , Kim DH , |
|
|
<i>Lactobacillus reuteri</i> DSM 17938 feeding of healthy newborn mice regulates immune responses while modulating gut microbiota and boosting beneficial metabolites. ✅
Go to Publication ✅
American journal of physiology. Gastrointestinal and liver physiology (Am J Physiol Gastrointest Liver Physiol ) Vol: Issue Pages: Pub: 2019 Sep 4 Epub: 2019 Sep 4 Authors Liu Y , Tian X , He B , Hoang TK , Taylor CM , Blanchard E , Freeborn J , Park S , Luo M , Couturier J , Tran DQ , Roos S , Wu G , Rhoads JM , |
|
|
<i>Lactobacillus reuteri</i> NK33 and <i>Bifidobacterium adolescentis</i> NK98 alleviate <i>Escherichia coli</i>-induced depression and gut dysbiosis in mice. ✅
Go to Publication ✅
Journal of microbiology and biotechnology (J Microbiol Biotechnol ) Vol: Issue Pages: Pub: 2020 Apr 29 Epub: 2020 Apr 29 Authors Han SK , Kim JK , Joo MK , Lee KE , Han SW , Kim DH , |
|
|
Lactobacillus reuteri Reduces the Severity of Experimental Autoimmune Encephalomyelitis in Mice by Modulating Gut Microbiota. ✅
Go to Publication ✅
Frontiers in immunology (Front Immunol ) Vol: 10 Issue Pages: 385 Pub: 2019 Epub: 2019 Mar 7 Authors He B , Hoang TK , Tian X , Taylor CM , Blanchard E , Luo M , Bhattacharjee MB , Freeborn J , Park S , Couturier J , Lindsey JW , Tran DQ , Rhoads JM , Liu Y , |
|
|
Lactobacillus reuteri strain 8008 attenuated the aggravation of depressive-like behavior induced by CUMS in high-fat diet-fed mice through regulating the gut microbiota. ✅
Go to Publication ✅
Frontiers in pharmacology (Front Pharmacol ) Vol: 14 Issue Pages: 1149185 Pub: 2023 Epub: 2023 Mar 27 Authors Li C , Su Z , Chen Z , Cao J , Liu X , Xu F , |
|
|
Lactobacillus reuteri strain 8008 attenuated the aggravation of depressive-like behavior induced by CUMS in high-fat diet-fed mice through regulating the gut microbiota. ✅
Go to Publication ✅
Frontiers in pharmacology (Front Pharmacol ) Vol: 14 Issue Pages: 1149185 Pub: 2023 Epub: 2023 Mar 27 Authors Li C , Su Z , Chen Z , Cao J , Liu X , Xu F , |
|
|
Lactobacillus reuteri strain 8008 attenuated the aggravation of depressive-like behavior induced by CUMS in high-fat diet-fed mice through regulating the gut microbiota. ✅
Go to Publication ✅
Frontiers in pharmacology (Front Pharmacol ) Vol: 14 Issue Pages: 1149185 Pub: 2023 Epub: 2023 Mar 27 Authors Li C , Su Z , Chen Z , Cao J , Liu X , Xu F , |
|
|
Dietary Lactobacillus reuteri SL001 Improves Growth Performance, Health-Related Parameters, Intestinal Morphology and Microbiota of Broiler Chickens. ✅
Go to Publication ✅
Animals : an open access journal from MDPI (Animals (Basel) ) Vol: 13 Issue 10 Pages: Pub: 2023 May 19 Epub: 2023 May 19 Authors Chai C , Guo Y , Mohamed T , Bumbie GZ , Wang Y , Zeng X , Zhao J , Du H , Tang Z , Xu Y , Sun W , |
|
|
Effects of drinking water supplementation with Lactobacillus reuteri, and a mixture of reuterin and microcin J25 on the growth performance, caecal microbiota and selected metabolites of broiler chickens. ✅
Go to Publication ✅
Journal of animal science and biotechnology (J Anim Sci Biotechnol ) Vol: 13 Issue 1 Pages: 34 Pub: 2022 Mar 5 Epub: 2022 Mar 5 Authors Zhang L , Ben Said L , Hervé N , Zirah S , Diarra MS , Fliss I , |
|
|
Inhibitory effects of different lactobacilli on Candida albicans hyphal formation and biofilm development. ✅
Journal of biological regulators and homeostatic agents (J Biol Regul Homeost Agents ) Vol: 28 Issue 4 Pages: 743-52 Pub: 2014 Oct-Dec Epub: Authors Orsi CF , Sabia C , Ardizzoni A , Colombari B , Neglia RG , Peppoloni S , Morace G , Blasi E , |
|
|
Antimicrobial and anti-adhesive properties of biosurfactant produced by lactobacilli isolates, biofilm formation and aggregation ability. ✅
The Journal of general and applied microbiology (J Gen Appl Microbiol ) Vol: 59 Issue 6 Pages: 425-36 Pub: 2013 Epub: Authors Zakaria Gomaa E , |
|
|
Efficacy of Limosilactobacillus reuteri UBLRu-87 in Infantile Colic and Its Symptoms: A Double-Blind, Placebo-Controlled Study. ✅
Go to Publication ✅
Cureus (Cureus ) Vol: 17 Issue 4 Pages: e81856 Pub: 2025 Apr Epub: 2025 Apr 7 Authors Venkataraman R , Kotyal Basvanyappa M , Samanta B , Yadla M , Ravi NA , Neelamraju J , Madempudi RS , |
|
|
Taking SCFAs produced by Lactobacillus reuteri orally reshapes gut microbiota and elicits antitumor responses. ✅
Go to Publication ✅
Journal of nanobiotechnology (J Nanobiotechnology ) Vol: 22 Issue 1 Pages: 241 Pub: 2024 May 12 Epub: 2024 May 12 Authors Li N , Niu L , Liu Y , Wang Y , Su X , Xu C , Sun Z , Guo H , Gong J , Shen S , |
|
|
Taking SCFAs produced by Lactobacillus reuteri orally reshapes gut microbiota and elicits antitumor responses. ✅
Go to Publication ✅
Journal of nanobiotechnology (J Nanobiotechnology ) Vol: 22 Issue 1 Pages: 241 Pub: 2024 May 12 Epub: 2024 May 12 Authors Li N , Niu L , Liu Y , Wang Y , Su X , Xu C , Sun Z , Guo H , Gong J , Shen S , |
|
|
Taking SCFAs produced by Lactobacillus reuteri orally reshapes gut microbiota and elicits antitumor responses. ✅
Go to Publication ✅
Journal of nanobiotechnology (J Nanobiotechnology ) Vol: 22 Issue 1 Pages: 241 Pub: 2024 May 12 Epub: 2024 May 12 Authors Li N , Niu L , Liu Y , Wang Y , Su X , Xu C , Sun Z , Guo H , Gong J , Shen S , |
BOOM
All suggestions are computed solely on their predicted microbiome impact. Safety, side-effects etc must be evaluated by your medical professionals before starting. Some items suggests have significant risk of adverse consequences for some people.
Special thanks to David F Morrison and Geert Van Houcke for doing Quality Assurance. Special thanks to Oliver Luk, B.Sc. (Biology) from BiomeSight for spot checking the coding of data from the US National Library of Medicine
This is an Academic site. It generates theoretical models of what may benefit a specific microbiome results.
Copyright 2016-2023 Lassesen Consulting, LLC [2007], DBA, Microbiome Prescription. All rights served.
Permission to data scrap or reverse engineer is explicitly denied to all users. U.S. Code Title 18 PART I CHAPTER 47 § 1030, CETS No.185, CFAA
Use of data on this site is prohibited except under written license. There is no charge for individual personal use. Use for any commercial applications or research requires a written license.
Caveat emptor: Analysis and suggestions are based on modelling (and thus infererence) based on studies. The data sources are usually given for those that wish to consider alternative inferences. theories and models.
Inventions/Methodologies on this site are Patent Pending.
Microbiome Prescription do not make any representations that data or analyses available on this site is suitable for human diagnostic purposes, for informing treatment decisions, or for any other purposes and accept no responsibility or liability whatsoever for such use.
This site is not Health Insurance Portability and Accountability Act of 1996 (HIPAA) compliant.
